4Arroyo V, Gines P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology, 1996,23: 164.
5Arroyo V, Gines P, Gerbes AL, et al. Deflnition and diagnostic criteria of refractory ascites and hepatorenal syndrorne in cirrhosis. Hepatology, 1996,23: 164.
5Salerno F, Gerbes A, Gin,s P, et al. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis [J]. Gut, 2007, 56 (9):1310-1318.
6Angeli P, Merkel C. Pathogenesis and management of hepatorenal syndrome in patients with cin'hosis[J]. J Hepatol, 2005, 48(Suppl 1):S93-S103.
7Angeli P, Guarda S, Fasolato S, et al. Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost[J]. Aliment Pharmacol Ther, 2006, 23(1):75-84.
8De las Heras D, Fernandez J, Gin,s P, et al.Increased carbon monoxide production in patients with cirrhosis with and without spontaneous bacterial peritonitis[J]. Hepatology, 2003, 38(2):452- 459.
9Fernandez J, Navasa M, Planas R, et al. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis[J]. Gastroenterology, 2007, 133(3): 818-824.
10Gines P, Guevara M, Arroyo V, et al. Hepatorenal syndrome[J]. Lancet, 2003, 362(9398):1819-1827.
